Recent studies suggest that gut microbiota-farnesoid X receptor (FXR) axis influence the pathogenesis of obesity-related metabolic dysfunction.The anti-oxidant tempol was found to remodel the gut microbiome by preferentially reducing the genus Lactobacillus leading to accumulation of intestinal tauro-β-muricholic acid,from decreased Lactobacillus-associated bile salt hydrolase activity.